Liposomal Formulations: A Recent Update
Pharmaceutics · 30.12.2024 · 17 (1) · 36
DOI: 10.3390/pharmaceutics17010036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 30.12.2024. Verfasst von Surendra S Agrawal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (M), Wardha 442001, Maharashtra, India. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liposome-based drug delivery technologies have showed potential in enhancing medication safety and efficacy. Innovative drug loading and release mechanisms highlighted in this review of next-generation liposomal formulations. Due to poor drug release kinetics and loading capacity, conventional liposomes have limited clinical use. Scientists have developed new liposomal carrier medication release control and encapsulation methods to address these limits. Drug encapsulation can be optimized by creating lipid compositions that match a drug’s charge and hydrophobicity. By selecting lipids and adding co-solvents or surfactants, scientists have increased drug loading in liposomal formulations while maintaining stability. Nanotechnology has also created multifunctional liposomes with triggered release and personalized drug delivery. Surface modification methods like PEGylation and ligand conjugation can direct liposomes to disease regions, improving therapeutic efficacy and reducing off-target effects. In addition to drug loading, researchers have focused on spatiotemporal modulation of liposomal carrier medication release. Stimuli-responsive liposomes release drugs in response to bodily signals. Liposomes can be pH- or temperature-sensitive. To improve therapeutic efficacy and reduce systemic toxicity, researchers added stimuli-responsive components to liposomal membranes to precisely control drug release kinetics. Advanced drug delivery technologies like magnetic targeting and ultrasound. Pro Drug, RNA Liposomes approach may improve liposomal medication administration. Magnetic targeting helps liposomes aggregate at illness sites and improves drug delivery, whereas ultrasound-mediated drug release facilitates on-demand release of encapsulated medicines. This review also covers recent preclinical and clinical research showing the therapeutic promise of next-generation liposomal formulations for cancer, infectious diseases, neurological disorders and inflammatory disorders. The transfer of these innovative liposomal formulations from lab to clinical practice involves key difficulties such scalability, manufacturing difficulty, and regulatory limits.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (M), Wardha 442001, Maharashtra, India.
- Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai 400056, Maharashtra, India.
ORCID-Profile: Vaishali Y Londhe
Zitieren
APA
Agrawal, S. S., Baliga, V., & Londhe, V. Y. (2024). Liposomal Formulations: A Recent Update. Pharmaceutics, 17(1), 36. https://doi.org/10.3390/pharmaceutics17010036
Vancouver
Agrawal SS, Baliga V, Londhe VY. Liposomal Formulations: A Recent Update. Pharmaceutics. 2024;17(1):36. doi:10.3390/pharmaceutics17010036
BibTeX
@article{Agrawal2024,
author = {Agrawal, Surendra S and Baliga, Vrinda and Londhe, Vaishali Y},
title = {Liposomal Formulations: A Recent Update},
journal = {Pharmaceutics},
year = {2024},
volume = {17},
number = {1},
pages = {36},
doi = {10.3390/pharmaceutics17010036}
}
EUVIMED